Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry Golombick

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
American Journal of Hematology|May 6, 2011
The impact of osteoporosis (as measured by lumbar spine quantitative computed tomography) on disease activity and survival in myeloma patients: a 13-year prospective studyTerrence Diamond, Terry Golombick, Arumugam Manoharan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2009
The potential role of curcumin in patients with monoclonal gammopathy of undefined significance--its effect on paraproteinemia and the urinary N-telopeptide of type I collagen bone turnover markerTerry Golombick, Terrence H Diamond, Vladimir Badmaev, et al.
American Journal of Hematology|July 1, 2020
Teriparatide (recombinant human parathyroid hormone 1-34) therapy in myeloma patients with severe osteoporosis and fractures despite effective anti-myeloma therapy and bisphosphonates: A pilot studyTerrence H Diamond, Terry Golombick, Arumugam Manoharan, et al.
Integrative Cancer Therapies|October 18, 2017
Evidence-Based Review of BioBran/MGN-3 Arabinoxylan Compound as a Complementary Therapy for Conventional Cancer TreatmentSoo Liang Ooi, Debbie McMullen, Terry Golombick, et al.
Clinical Case Reports|April 11, 2020
Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapyRajeev Ramakrishna, Terrence H Diamond, William Alexander, et al.
Clinical Medicine Insights. Blood Disorders|November 18, 2017
Effect of the Ginger Derivative, 6-Shogaol, on Ferritin Levels in Patients With Low to Intermediate-1-Risk Myelodysplastic Syndrome-A Small, Investigative StudyTerry Golombick, Terrence H Diamond, Arumugam Manoharan, et al.
Integrative Cancer Therapies|December 21, 2021
Is 6-Shogaol an Effective Phytochemical for Patients With Lower-risk Myelodysplastic Syndrome? A Narrative ReviewSoo Liang Ooi, Ron Campbell, Sok Cheon Pak, et al.
Scientific Reports|March 2, 2026
Effects of rice bran arabinoxylan compound on quality of life of cancer patients during active treatment: a randomised placebo-controlled pilot trialSoo Liang Ooi, Peter S Micalos, Robert Zielinski, et al.
Contemporary Clinical Trials Communications|June 18, 2020
Rice bran arabinoxylan compound and quality of life of cancer patients (RBAC-QoL): Study protocol for a randomized pilot feasibility trialSoo Liang Ooi, Sok Cheon Pak, Peter S Micalos, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
American Journal of Hematology|May 6, 2011
The impact of osteoporosis (as measured by lumbar spine quantitative computed tomography) on disease activity and survival in myeloma patients: a 13-year prospective studyTerrence Diamond, Terry Golombick, Arumugam Manoharan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2009
The potential role of curcumin in patients with monoclonal gammopathy of undefined significance--its effect on paraproteinemia and the urinary N-telopeptide of type I collagen bone turnover markerTerry Golombick, Terrence H Diamond, Vladimir Badmaev, et al.
American Journal of Hematology|July 1, 2020
Teriparatide (recombinant human parathyroid hormone 1-34) therapy in myeloma patients with severe osteoporosis and fractures despite effective anti-myeloma therapy and bisphosphonates: A pilot studyTerrence H Diamond, Terry Golombick, Arumugam Manoharan, et al.
Integrative Cancer Therapies|October 18, 2017
Evidence-Based Review of BioBran/MGN-3 Arabinoxylan Compound as a Complementary Therapy for Conventional Cancer TreatmentSoo Liang Ooi, Debbie McMullen, Terry Golombick, et al.
Clinical Case Reports|April 11, 2020
Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapyRajeev Ramakrishna, Terrence H Diamond, William Alexander, et al.
Clinical Medicine Insights. Blood Disorders|November 18, 2017
Effect of the Ginger Derivative, 6-Shogaol, on Ferritin Levels in Patients With Low to Intermediate-1-Risk Myelodysplastic Syndrome-A Small, Investigative StudyTerry Golombick, Terrence H Diamond, Arumugam Manoharan, et al.
Integrative Cancer Therapies|December 21, 2021
Is 6-Shogaol an Effective Phytochemical for Patients With Lower-risk Myelodysplastic Syndrome? A Narrative ReviewSoo Liang Ooi, Ron Campbell, Sok Cheon Pak, et al.
Scientific Reports|March 2, 2026
Effects of rice bran arabinoxylan compound on quality of life of cancer patients during active treatment: a randomised placebo-controlled pilot trialSoo Liang Ooi, Peter S Micalos, Robert Zielinski, et al.
Contemporary Clinical Trials Communications|June 18, 2020
Rice bran arabinoxylan compound and quality of life of cancer patients (RBAC-QoL): Study protocol for a randomized pilot feasibility trialSoo Liang Ooi, Sok Cheon Pak, Peter S Micalos, et al.
Pageof 2